Literature DB >> 19628258

Second primary cancer risk of radiation therapy after radical prostatectomy for prostate cancer: an analysis of SEER data.

May Abdel-Wahab1, Isildinha M Reis, Jiuhua Wu, Robert Duncan.   

Abstract

OBJECTIVES: To determine the incidence of second primary cancer (SPC) and primary pelvic late SPC/radiation-induced SPC after radical prostatectomy and radiation.
METHODS: A total of 228 235 prostate cancer patients in the 1973-2002 Surveillance, Epidemiology, and End Results database were studied. The age-adjusted estimates of SPCs was calculated. Competing risk multivariable Cox proportional hazards regression analysis was adjusted for age at diagnosis, race or ethnicity, and radiation and was used to evaluate the effect of treatment on SPC.
RESULTS: The overall incidence of SPC was 8.4%. The most frequent pelvic SPCs were bladder (2303 cases), rectum or rectosigmoid junction (1006 cases). The most frequent nonpelvic SPCs were bronchus and lung (4131 cases), colon (2665 cases), and skin (1769 cases). The absolute risk of developing a second malignancy was 1747 cases per 100 000 in the "Radical surgery and x-ray treatment" group and 1581 in the "radical surgery" group. With regard to late primary pelvic SPC, a higher age-adjusted rate of 374 cases per 100 000 was seen in the radiated group.
CONCLUSIONS: Radiation after radical surgery increased late primary pelvic SPC. No increases were seen in secondary pelvic or extrapelvic SPCs.

Entities:  

Mesh:

Year:  2009        PMID: 19628258     DOI: 10.1016/j.urology.2009.02.085

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  10 in total

Review 1.  Cancer risk related to gastrointestinal diagnostic radiation exposure.

Authors:  Mimi L Chang; Jason K Hou
Journal:  Curr Gastroenterol Rep       Date:  2011-10

Review 2.  Second malignant neoplasms and cardiovascular disease following radiotherapy.

Authors:  Lois B Travis; Andrea K Ng; James M Allan; Ching-Hon Pui; Ann R Kennedy; X George Xu; James A Purdy; Kimberly Applegate; Joachim Yahalom; Louis S Constine; Ethel S Gilbert; John D Boice
Journal:  J Natl Cancer Inst       Date:  2012-02-06       Impact factor: 13.506

3.  Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors.

Authors:  Amy Berrington de Gonzalez; Jeannette Wong; Ruth Kleinerman; Clara Kim; Lindsay Morton; Justin E Bekelman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-02-01       Impact factor: 7.038

Review 4.  Accelerated Premalignant Polyposis and Second Colon Cancers: Incriminating Immunosuppression, Radiotherapy, and Systemic Chemotherapy Agents.

Authors:  Frank J Senatore; Shruti Murali; Constantin A Dasanu
Journal:  J Gastrointest Cancer       Date:  2016-06

5.  Effect of external beam radiotherapy on second primary cancer risk after radical prostatectomy.

Authors:  Felix Preisser; Elio Mazzone; Sophie Knipper; Sebastiano Nazzani; Marco Bandini; Shahrokh F Shariat; Michele Marchioni; Zhe Tian; Fred Saad; Daniel Taussky; Alberto Briganti; Hartwig Huland; Markus Graefen; Derya Tilki; Pierre I Karakiewicz
Journal:  Can Urol Assoc J       Date:  2019-11-29       Impact factor: 1.862

Review 6.  Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment technique.

Authors:  Louise Murray; Ann Henry; Peter Hoskin; Frank-Andre Siebert; Jack Venselaar
Journal:  Radiother Oncol       Date:  2014-01-30       Impact factor: 6.280

7.  Risk of second cancer following radiotherapy for prostate cancer: a population-based analysis.

Authors:  Nina-Sophie Hegemann; Anne Schlesinger-Raab; Ute Ganswindt; Claudia Hörl; Stephanie E Combs; Dieter Hölzel; Jürgen E Gschwend; Christian Stief; Claus Belka; Jutta Engel
Journal:  Radiat Oncol       Date:  2017-01-03       Impact factor: 3.481

8.  Racial differences in the risk of second primary bladder cancer following radiation therapy among localized prostate cancer patients.

Authors:  Lu Zhang; Mei-Chin Hsieh; Claire Allison; Michael Devane; Chindo Hicks; Qingzhao Yu; Lu Shi; Jiande Wu; Xiao-Cheng Wu
Journal:  Cancer Epidemiol       Date:  2021-06-17       Impact factor: 2.890

Review 9.  High prevalence of secondary bladder cancer in men on radiotherapy for prostate cancer: evidence from a meta-analysis.

Authors:  Shankun Zhao; Qiang Xie; Redian Yang; Jiamin Wang; Chaofeng Zhang; Lianmin Luo; Zhiguo Zhu; Yangzhou Liu; Ermao Li; Zhigang Zhao
Journal:  Cancer Manag Res       Date:  2019-01-10       Impact factor: 3.989

Review 10.  Urological complications after radiation therapy-nothing ventured, nothing gained: a Narrative Review.

Authors:  Joanna Chorbińska; Wojciech Krajewski; Romuald Zdrojowy
Journal:  Transl Cancer Res       Date:  2021-02       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.